RIGL R&D to Revenue
Rigel Pharmaceuticals Inc · R&D to Revenue
RIGL R&D to Revenue
Latest reported11.31%period ending
RIGL FY R&D/Revenue (190.47% → 11.31%)
Latest values, visible window
High-resolution chart · PNG
RIGL r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 11.314% | |
| 13.0412% | |
| 20.9801% | |
| 50.1256% | |
| 43.714% | |
| 55.3309% | |
| 89.2002% | |
| 105.3787% | |
| 1,031.8689% | |
| 311.2692% | |
| 217.4252% | |
| 820.5576% | |
| 1,053.5385% | |
| 3,501.2444% | |
| 1,460% | |
| 51.5136% | |
| 12,099.0667% | |
| 0% | |
| 558.4444% | |
| 170.1909% | |
| 314.8856% | |
| 1,025.206% | |
| 392.2479% | |
| 274.5756% | |
| 211.1547% | |
| 242.3513% | |
| 190.472% |